Benzinga's Top #PreMarket Gainers
September 24, 2014 at 08:05 AM EDT
Merrimack Pharmaceuticals (NASDAQ: MACK) shares jumped 25.17% to $9.00 in pre-market trading on licensing deal with Baxter International ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.